Disease Models & Mechanisms

Progress in PD research and therapeutic development is hindered by many challenges, including a need for robust preclinical animal models. Limited availability of these tools is due to technical hurdles, patent issues, licensing restrictions and the high costs associated with generating and distributing these animal models. Furthermore, the lack of standardized data makes it difficult to evaluate different animal models. This paper describes MJFF's strategy of generating, characterizing and distributing rodent models, and explores the many ways that these models could be used to promote PD research and drug development.

Authors: